Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study.
Trestini I, Belluomini L, Dodi A, Sposito M, Caldart A, Kadrija D, Pasqualin L, Riva ST, Scaglione IM, Tregnago D, Avancini A, Insolda J, Confortini L, Casali M, Menis J, Vita E, Cintoni M, Todesco M, Milanese G, Sperduti I, D'Onofrio M, Infante M, Tiseo M, Mele MC, Tortora G, Milella M, Bria E, Pilotto S. Trestini I, et al. Among authors: riva st. J Cachexia Sarcopenia Muscle. 2024 Dec;15(6):2349-2360. doi: 10.1002/jcsm.13568. Epub 2024 Oct 22. J Cachexia Sarcopenia Muscle. 2024. PMID: 39439222 Free PMC article.
Exploring machine learning tools in a retrospective case-study of patients with metastatic non-small cell lung cancer treated with first-line immunotherapy: A feasibility single-centre experience.
Ogliari FR, Traverso A, Barbieri S, Montagna M, Chiabrando F, Versino E, Bosco A, Lin A, Ferrara R, Oresti S, Damiano G, Viganò MG, Ferrara M, Riva ST, Nuccio A, Venanzi FM, Vignale D, Cicala G, Palmisano A, Cascinu S, Gregorc V, Bulotta A, Esposito A, Tacchetti C, Reni M. Ogliari FR, et al. Among authors: riva st. Lung Cancer. 2024 Dec 31;199:108075. doi: 10.1016/j.lungcan.2024.108075. Online ahead of print. Lung Cancer. 2024. PMID: 39752796
Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle?
Venanzi FM, Bini M, Nuccio A, De Toma A, Lambertini M, Ogliari FR, Oresti S, Viganò MG, Brioschi E, Polignano M, Naldini MM, Riva S, Ferrara M, Fogale N, Damiano G, Russo V, Reni M, Veronesi G, Foggetti G, Conforti F, Bulotta A, Ferrara R. Venanzi FM, et al. Cancer Treat Rev. 2023 Dec;121:102648. doi: 10.1016/j.ctrv.2023.102648. Epub 2023 Oct 26. Cancer Treat Rev. 2023. PMID: 37918169 Review.
Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies.
Nuccio A, Viscardi G, Salomone F, Servetto A, Venanzi FM, Riva ST, Oresti S, Ogliari FR, Viganò M, Bulotta A, Cameron R, Esposito A, Hines J, Bianco R, Reni M, Cascone T, Garassino MC, Torri V, Veronesi G, Cinquini M, Ferrara R. Nuccio A, et al. Among authors: riva st. Eur J Cancer. 2023 Dec;195:113404. doi: 10.1016/j.ejca.2023.113404. Epub 2023 Oct 26. Eur J Cancer. 2023. PMID: 37948842
Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients.
Arenare L, Porta C, Barberio D, Terzolo S, Zagonel V, Pisconti S, Del Mastro L, Pinto C, Bilancia D, Cinieri S, Rizzo M, Migliaccio G, Montesarchio V, Del Campo L, De Lorenzo F, Iannelli E, Traclò F, Gitto L, Vaccaro MC, Frontini L, Giannarelli D, Bryce J, Piccirillo MC, Jommi C, Efficace F, Riva S, Di Maio M, Gallo C, Perrone F. Arenare L, et al. ESMO Open. 2023 Dec;8(6):102192. doi: 10.1016/j.esmoop.2023.102192. Epub 2023 Dec 5. ESMO Open. 2023. PMID: 38052104 Free PMC article.
Integrating supportive care into the multidisciplinary management of lung cancer: we can't wait any longer.
Avancini A, Belluomini L, Borsati A, Riva ST, Trestini I, Tregnago D, Dodi A, Lanza M, Pompili C, Mazzarotto R, Micheletto C, Motton M, Scarpa A, Schena F, Milella M, Pilotto S. Avancini A, et al. Among authors: riva st. Expert Rev Anticancer Ther. 2022 Jul;22(7):725-735. doi: 10.1080/14737140.2022.2082410. Epub 2022 May 30. Expert Rev Anticancer Ther. 2022. PMID: 35608060
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned.
Belluomini L, Riva ST, Simbolo M, Nocini R, Trestini I, Avancini A, Tregnago D, Ferrara MG, Caldart A, Dodi A, Caliò A, Bria E, Scarpa A, Milella M, Menis J, Pilotto S. Belluomini L, et al. Among authors: riva st. Cells. 2021 Oct 7;10(10):2685. doi: 10.3390/cells10102685. Cells. 2021. PMID: 34685665 Free PMC article. Review.
Study Design and Rationale for Espera Trial: A Multicentre, Randomized, Phase II Clinical Trial Evaluating the Potential Efficacy of Adding SBRT to Pembrolizumab-Pemetrexed Maintenance in Responsive or Stable Advanced Non-Squamous NSCLC After Chemo-Immunotherapy Induction.
Belluomini L, Dionisi V, Palmerio S, Vincenzi S, Avancini A, Casali M, Riva ST, Menis J, Mazzarotto R, Pilotto S, Milella M. Belluomini L, et al. Among authors: riva st. Clin Lung Cancer. 2022 May;23(3):e269-e272. doi: 10.1016/j.cllc.2021.07.004. Epub 2021 Jul 20. Clin Lung Cancer. 2022. PMID: 34470722 Clinical Trial.
Infections and Immunotherapy in Lung Cancer: A Bad Relationship?
Belluomini L, Caldart A, Avancini A, Dodi A, Trestini I, Kadrija D, Sposito M, Tregnago D, Casali M, Riva ST, Sartori G, Menis J, Milella M, Pilotto S. Belluomini L, et al. Among authors: riva st. Int J Mol Sci. 2020 Dec 22;22(1):42. doi: 10.3390/ijms22010042. Int J Mol Sci. 2020. PMID: 33375194 Free PMC article. Review.
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic.
Zuliani S, Zampiva I, Tregnago D, Casali M, Cavaliere A, Fumagalli A, Merler S, Riva ST, Rossi A, Zacchi F, Zaninotto E, Auriemma A, Pavarana M, Soldà C, Benini L, Borghesani M, Caldart A, Casalino S, Gaule M, Kadrija D, Mongillo M, Pesoni C, Biondani P, Cingarlini S, Fiorio E, Melisi D, Parolin V, Tondulli L, Belluomini L, Zecchetto C, Avesani B, Biasi A, Bovo C, Dazzani E, Dodi A, Gelmini S, Leta LC, Lo Cascio G, Lombardo F, Lucin E, Martinelli IA, Messineo L, Moscarda V, Pafumi S, Reni A, Sartori G, Scaglione IM, Shoval Y, Sposito M, Tacconelli E, Trestini I, Zambonin V, Zanelli S, Pilotto S, Milella M. Zuliani S, et al. Among authors: riva st. Eur J Cancer. 2020 Aug;135:159-169. doi: 10.1016/j.ejca.2020.05.029. Epub 2020 Jun 11. Eur J Cancer. 2020. PMID: 32580131 Free PMC article.